Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
291.9 SEK | -0.14% | -0.71% | +11.50% |
Mar. 11 | Indutrade Closes Acquisition of Sweden-based Hemomatik | MT |
Mar. 11 | Indutrade AB (OM:INDT) agreed to acquire Hemomatik Ab. | CI |
Sales 2024 * | 32.23B 3.01B | Sales 2025 * | 33.95B 3.17B | Capitalization | 106B 9.92B |
---|---|---|---|---|---|
Net income 2024 * | 2.91B 272M | Net income 2025 * | 3.21B 299M | EV / Sales 2024 * | 3.47 x |
Net Debt 2024 * | 5.64B 527M | Net Debt 2025 * | 3.39B 316M | EV / Sales 2025 * | 3.23 x |
P/E ratio 2024 * |
36.4
x | P/E ratio 2025 * |
33.1
x | Employees | 9,301 |
Yield 2024 * |
1.12% | Yield 2025 * |
1.21% | Free-Float | 73.11% |
Latest transcript on Indutrade AB
1 day | -0.14% | ||
1 week | -0.71% | ||
Current month | +6.53% | ||
1 month | +5.68% | ||
3 months | +11.28% | ||
6 months | +44.29% | ||
Current year | +11.50% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 59 | 17-04-25 | |
Patrik Johnson
DFI | Director of Finance/CFO | 54 | 18-03-31 |
Åsa Wirsenius
HRO | Human Resources Officer | 47 | 17-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 43 | 15-04-29 | |
Ulf Lundahl
BRD | Director/Board Member | 72 | 05-12-31 |
Director/Board Member | 70 | 12-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.09% | 144 M€ | +4.93% | - | |
0.08% | 6 M€ | -.--% | - | |
0.04% | 6 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 291.9 | -0.14% | 151,463 |
24-03-27 | 292.3 | +0.38% | 176,705 |
24-03-26 | 291.2 | +0.07% | 158,077 |
24-03-25 | 291 | -1.49% | 225,820 |
24-03-22 | 295.4 | +0.48% | 132,159 |
Delayed Quote Nasdaq Stockholm, March 28, 2024 at 07:59 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.50% | 9.95B | |
+4.18% | 79.11B | |
+20.64% | 71.37B | |
+22.77% | 38.31B | |
+13.01% | 31.25B | |
+16.83% | 30.23B | |
+8.99% | 27.91B | |
+0.92% | 26.38B | |
+14.02% | 24.87B | |
+15.20% | 24.34B |